
ã¹ãã€ã¯ã¿ã³ãã¯è³ªã®ãããã¯ã¹ãªã¹ãïŒ-1(1~4)ãã2022.5.3æŽæ°ãããããã~äžçå¥åº·è©è°äŒ~ããããããã
ïŒããããã¯ã¹å¯Ÿè±¡ã®ã¯ã¯ãã³æ¥çš®ã«å¯ŸããŠã®äœã®åã/çç¶ã®èª¬æ
Covid-19ææçãCovid-19ã¯ã¯ãã³ãã¹ãã€ã¯ã¿ã³ãã¯è³ªã®å®³ã¯ã€ãæè¿ã®èª²é¡ã ããã®ã¬ã€ãã¯ä»ãŸã§ã®å»åŠç ç©¶ããã³æ°ããå»åŠç ç©¶ããããŠåœéçãªå»åž«ãããªã¹ãã£ãã¯ãã«ã¹å®è·µè ã®èšåºçµéšã«åºã¥ããŠããã~â æ°ããæ å ±ãåºãåºŠã«æŽæ°~
察象è (ã»ãŒå šäººé¡)
â Covid-19ã¯ã¯ãã³ãæ¥çš®ããããšãããããã
â¡æè¿Covid-19ã¯ã¯ãã³ã泚å°ãããããããããâ¢Covid-19ã¯ã¯ãã³ã®å¯äœçšã«é¢é£ãããšæãããçç¶ïŒã·ã§ãã£ã³ã°ãšãåŒã°ããïŒãããå Žåã
1ã€ãŸãã¯è€æ°ã®ã¢ã€ãã ã䜿çšãããšå¹æãããå¯èœæ§ãããã
éèŠãªãç¥ããïŒãã®ã¬ã€ãã¯æè²ç®çã®ã¿ã§ãããã¯ã¯ãã³æ¥çš®åŸã«äœèª¿ãæªããªã£ãå Žåã¯ãå°éå»ã«ãCovid-19泚å°åŸã®ç æ°ã«ã€ããŠã¯ãWCH泚å°åŸã¬ã€ããåç §ã
ã¹ãã€ã¯ã¿ã³ãã¯è³ªã¯ããã¹ãŠã®SARS-CoV-2äºçš®ã«å«ãŸããå¯èœæ§ãããããŸããCovid-19泚å°ãåãããšãã«ãäœå ã§çæããããããšãçç¶ããªããã³ããã-19ã®æ€æ»ã§éœæ§ãšãªããæ³šå°åŸã«å¯äœçšãåºããšããŠããäœå ã«ã¹ãã€ã¯ã¿ã³ãã¯è³ªãæ®ã£ãŠããå¯èœæ§ãããã
ææçãæ³šå°ã®åŸãã§ããã ãæ©ãã¹ãã€ã¯ã¿ã³ãã¯è³ªãäœå€ã«æåºããããšïŒä»¥äžããããã¯ã¹ïŒããäœå ã«æ®ã£ãŠããã埪ç°ããŠããã¹ãã€ã¯ã¿ã³ãã¯è³ªã«ãããã¡ãŒãžãã身ãå®ãããšã«ã€ãªãããšèããããŠããã
ð±ð±ð±ð±ð±ð±ð±ð±ð±ð±ð±ð±ð±ð±
ãããã¯ã¹ã§å¯Ÿè±¡ãšãªãäœã®åã·çç¶ã«ã€ããŠèª¬æð¶ã¹ãã€ã¯ã¿ã³ãã¯è³ªãspike proteinð¶(ãŠã€ã«äŸµå ¥ã«ãŒã)
â¶èªç¶æææã«ã¯ãã¹ãã€ã¯ã¿ã³ãã¯è³ªã¯ããŠã€ã«ã¹ãäœå ã®çްèã«äŸµå ¥ããã®ãå©ããéèŠãªåœ¹å²ãæãããâ¬ïžâ¬ïžâ¬ïž
â·ã¹ãã€ã¯ã¿ã³ãã¯è³ªãç Žå£ããããã«ãèªåã®çްèãå ç«ã·ã¹ãã ã®ã¿ãŒã²ãããšãªããâ¬ïžâ¬ïžâ¬ïž
âžã¹ãã€ã¯ã¿ã³ãã¯è³ªã«å¯Ÿããå ç«ç³»ã®åå¿ã¯ãäœã®çްèã«ãã¡ãŒãžãäžããå¯èœæ§ãããã®ã§ãããã¯ã¹ãå¿ èŠã
â»ã¹ãã€ã¯ã¿ã³ãã¯è³ªã¯ãŠã€ã«ã¹ã®äžã§ãæ¯æ§ã匷ãéšåã§ãããã¯ã¯ãã³ã«ããæ¯æ§ãšã®é¢é£æ§ã®ç ç©¶ã¯çŸåšãé²è¡äžã
âïžçŽ°èæ žå ã§ã¯ãã¹ãã€ã¯ã¿ã³ãã¯è³ªã现èã®DNA修埩èœåãæãªããšããæ°ããªèšŒæ ãåŸãããŠãã
âïžãŠã€ã«ã¹ã®ã¹ãã€ã¯ã¿ã³ãã¯è³ªã¯ãè¡æ ãè³é§ãçµç¹æ§èºçãå¿ççãªã©ã®æå®³äœçšãšé¢é£ããããšãããŠãããWCH泚å°åŸã¬ã€ãã§èª¬æãããŠããCovid-19ã¯ã¯ãã³ã®å¯äœçšã®å€ãã¯ããããããã®ã¹ãã€ã¯ã¿ã³ãã¯è³ªãåå ã§ãããšæãããã
âïžãã¡ã€ã¶ãŒç€Ÿè£œã¯ã¯ãã³ã®æ¥æ¬ã§ã®çäœå ååžèª¿æ»ã«ãããšãæ¥çš®åŸ48æéã§ã¯ã¯ãã³ç²åãå šèº«ã®æ§ã ãªçµç¹ã«ç§»åããæ³šå°éšäœã«ãšã©ãŸãããèèã骚é«ãåµå·£ã§é«æ¿åºŠã確èªãããã
âïžã¹ãã€ã¯çã«é¢ããæ°ããªèšŒæ ã¯ãã¹ãã€ã¯ã¿ã³ãã¯è³ªãèç©ãããããããçµç¹ã§ãççãååºã«é¢é£ãã圱é¿ãçºçããå¯èœæ§ã瀺åã
âïžããã«ãããŠã¹ãçšããå°éå®¶ã®ç ç©¶ã«ãããã¹ãã€ã¯ã¿ã³ãã¯è³ªã¯è¡æ¶²è³é¢éãééããããšãå¯èœã§ããããšãããã£ããåŸã£ãŠãããã®å Žåãäœå ããæåºãããªããšç¥çµåŠçãªæå·ãåŒãèµ·ããå¯èœæ§ãããã
â¡â¡â¡â¡â¡â¡â¡â¡â¡â¡â¡â¡â¡â¡
ð¶ACE2å容äœãACE2 receptor(äŸµå ¥ã«ãŒããšãã£ã€ã)ð¶
ACE2å容äœã¯ã现èå£ãèºãè¡ç®¡ã®å
èãè¡å°æ¿ã«ååšãã¹ãã€ã¯ã¿ã³ãã¯è³ªã¯ACE2å容äœã«ãã£ã€ããâ¬ïžâ¬ïžâ¬ïž
倧éã®ã¹ãã€ã¯ã¿ã³ãã¯è³ªãç§ãã¡ã®ACE2å容äœã«çµåããäºå®äžãå± åº§ã£ãŠãæ§ã ãªçµç¹ã«ãããå容äœã®æ£åžžãªæ©èœãé»å®³ããŠããå¯èœæ§ã瀺åãããŠããããããã®å容äœã®ç Žå£ã¯ãçµç¹æ©èœã®å€åãéããŠãå€ãã®æå®³äœçšãšé¢é£ããŠããã
现èå£ã«çµåãã¿ãŒã³:å ç«ç³»ãå¥åº·ãªçްèãæ»æããåŒãéãšãªããèªå·±å ç«çŸæ£ãåŒãèµ·ããå¯èœæ§ãããã
è¡å°æ¿ãè¡ç®¡ãèŠãå ç®çްèãšçµåãã¿ãŒã³:ç°åžžåºè¡ãååºãåŒãèµ·ããå¯èœæ§ãããããããã¯ããããã¯ã¯ãã³èµ·å æ§è¡å°æ¿æžå°çïŒVITTïŒãšé¢é£ããŠããã
â¡â¡â¡â¡â¡â¡â¡â¡â¡â¡â¡â¡â¡â¡
ð¶ã€ã³ã¿ãŒãã€ãã³ã6Interleukin-6(è «ãã®å )ð¶
ã€ã³ã¿ãŒãã€ãã³6(IL-6)ã¯ãäž»ã«ççæ§ãµã€ãã«ã€ã³ã¿ã³ãã¯è³ªãã€ãŸããææçãçµç¹ã®æå·ã«åå¿ããŠäœå
ã§èªç¶ã«ç£çãããççåå¿ãéå§ãããã
ðIL-6ãªã©ã®ãµã€ãã«ã€ã³ããææããŠããªãäººãšæ¯èŒããŠãCovid-19ã«ææãã人ã®éã§ã¯ããã«é«ãæ°å€ã«ãªãã
ðIL-6ã¯ãCovid-19é²è¡ã®ç ç¶ãçåœäœã®ç¶æ ã®ææšãšããŠäœ¿çšãããŠããã
ðIL-6ã®å¢å ã¯ãåŒåžåšæ©èœé害ãæã€æ£è ã§ç¢ºèªãããŠããã
ðIL-6 ã¬ãã«ã¯ãICU æ£è ã® T çŽ°èæ°ãšéçžé¢ããŠããã
ðIL-6ãªã©ã®ççæ§ãµã€ãã«ã€ã³ã¯ã¯ã¯ãã³æ¥çš®åŸã«ãçºçŸããè³ã«å°éããå¯èœæ§ãããããšãç ç©¶ã§ç€ºåãããŠããã
ãªããããã¯ã¹å¯Ÿè±¡ãªã®ã?â¡ïžããã€ãã®å€©ç¶ç©è³ªã¯ãIL6ãæšçãšããããšã§ãæ¥çš®åŸã®è§£æ¯ããã»ã¹ãå©ããçºã
â¡â¡â¡â¡â¡â¡â¡â¡â¡â¡â¡â¡â¡â¡
ð¶ããŒãªã³ãfurin(ãŠã€ã«ã¹ã现èã«å ¥ã蟌ããããã«ãã)ð¶
ããŒãªã³ãšã¯ïŒ
ã¿ã³ãã¯è³ªãåæããçç©åŠçã«æŽ»æ§åãããé µçŽ ã§ããã
ãªããããã¯ã¹å¯Ÿè±¡ãªã®ã?â¬ïž
ããŒãªã³ã¯ã¹ãã€ã¯ã¿ã³ãã¯è³ªãåé¢ããããããŠãŠã€ã«ã¹ãããã®çްèã«å ¥ã蟌ãããšãå¯èœã«ããããšãåãã£ãŠããã
Covid-19ã®ã¹ãã€ã¯ã¿ã³ãã¯è³ªã«ã¯ããŒãªã³ã®åæéšäœãååšããããããŠã€ã«ã¹ã®ææåãäŒéåãé«ããŠãããšèããããŠããã
ããŒãªã³é»å®³å€ã¯ãã¹ãã€ã¯ã¿ã³ãã¯è³ªã®åæãé»å®³ããããšã§å¹æãçºæ®ããŸãã
â¡â¡â¡â¡â¡â¡â¡â¡â¡â¡â¡â¡â¡â¡
ð¶ã»ãªã³ãããã¢ãŒãŒãserine protease(ãŠã€ã«ã¹äŸµå ¥ã«ãŒããæŽ»æ§åããã)ð¶
ã»ãªã³ãããã¢ãŒãŒã¯é
µçŽ ã®äžçš®ã ãããªããããã¯ã¹å¯Ÿè±¡ãªã®ã?â¬ïž
ã»ãªã³ãããã¢ãŒãŒãé»å®³ããããšã§ãã¹ãã€ã¯ã¿ã³ãã¯è³ªã®æŽ»æ§åãé²ãããŠã€ã«ã¹ã®çްèãžã®äŸµå ¥ãæããããšãã§ãããããææçãéç床ãäœäžãããããšãã§ãããšèããããŠããã
ðððððððððððððð
ðð¬EriQmapJapanã¡ãã£ã¢ãã«(QAJFåç»)ãhttps://mediable.jp/channels/a1702ee5-1e80-42b3-b5cd-bfb2f0a479b0
ðã©ã€ã³ð
ã¢ã«ãŠã³ãIDæ€çŽ¢:@339jejrlã
ãªã³ã¯:https://liff.line.me/1645278921-kWRPP32q/?accountId=339jejrl
ðTelegramð
ðžQAJFå ¬åŒ(äž»ã«éå¡ã®æçš¿) https://t.me/QArmyJapanFlynn
ðžQAJFãã£ãã(äž»ã«éå¡ã®æçš¿ã®chat) https://t.me/QArmyJapanFlynnChat
ðžEri&QmapJapan(Eriããæçš¿ãŸãšã) https://t.me/EriAndQmapJapan
ðžEriãã£ãã(QAJFãšanonããã®æèŠåºå Ž) https://t.me/+wgUQKKmwlBBmNGU1
ðžãžã£ãã³ã°ãªãŒã³ãã©ãŽã³(å°åæ å ±Â·QT meet upæ å ±) https://t.me/joinchat/xqUZvIe1uYg1YTQx
ðQAJFè³æé€š https://t.me/qajfhistory
ðŒQAJFããŒã çŸè¡é€šãhttps://t.me/qajfmeme
ðEriããgabã¢ã«ãŠã³ãhttps://gab.com/EriQmapJapan
ðEriããããã°(ãµãã¹ã¿ãã¯)ãhttps://eriqmapjapan.substack.com/p/7f0?s=w
â€ïžQAJFããŒã ããŒãžâ€ïžhttps://qajf.github.io/
ðŒããŒã ããŒãžå 容â¬ïžðŒ
â¶Qã ãŒãŽã¡ã³ãã£ãŠäœïŒhttps://qajf.github.io/q
â·8kunã£ãŠäœïŒhttps://qajf.github.io/qresearch
âžâŠQposts.inïŒQãã¹ãæ€çŽ¢ããŒã«ïŒhttps://qposts.in/japaneseãâŠQmapJapan.pub(Eriãã翻蚳Qãããã/éå»ã®Qããããæ¥æ¬èªèš³ã埩å äž)ãhttps://qajf-qmapjapan-pub.officialblog.jp/
â¹QAJFåç»https://odysee.com/@QArmyJapanFlynn_OFFICIAL:5
âºãªã¢ã«æŽ»åæ¡å ãQT meet up åä»ã¯ãã¡ãããâ¡ïžhttps://qajf.github.io/event
â»ãã€ãã£ã¹é ä¿¡è ãªã¹ãhttps://tarouxx7.wixsite.com/mysite
âŒéå¡ãªã¹ãhttps://senyouyo.wixsite.com/account
âœéå¡éã®æŽ»å:ããã°çhttps://qajf.github.io/link
âŸéå»Twitteræçš¿ãŸãšã(2019幎5æã2020幎11æ9æ¥ãŸã§ïŒhttp://qajf.tk
â¿ã¬ãããã«ãã¥ãŒã¹(æ¥ã ã®æ å ±ãŸãšã)https://qajf.officialblog.jp/
âªQ掻åããŒã«(ãã©ã·çããŠã³ããŒãå¯)https://qajf.github.io/tools
â«ã©ãžãªæŸéã第1·3æ¥æ 22:30~ããQAJFãã¬ãããã«ã©ãžãªã·ã§ãŒã
ðQAJFå ¬åŒã®HPâ¡ïžhttps://qajf.github.io/radio
ðã¬ãããã«ã©ãžãªã·ã§ãŒHPâ¡ïžhttps://redpill-radio.info/about/
ãªã¯ãšã¹ãããæèŠãåŸ ã¡ããŠãããŸãðhttps://redpill-radio.info/start/
ðåžå·ãããFMã®HPâ¡ïžhttp://www.fmu.co.jp/redpillradio.html